HubSpot (HUBS) Lowered to Hold at Zacks Investment Research

Share on StockTwits

HubSpot (NYSE:HUBS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Thursday.

According to Zacks, “HubSpot provides inbound marketing and sales application over the cloud. The company also raised its fiscal 2018 guidance. We believe portfolio expansion and collaborations bode well. The company is benefitting from an expanding international footprint. Robust performance of Hubspot One and Hubspot CRM tools is a positive. HubSpot’s product portfolio is gaining from integration with Shopify & Facebook, which leverage AI. Adoption of Google cloud remains a positive. Moreover, integration of its various in house offerings is likely to improve subscription levels going ahead, consequently bolstering the top line. Notably, shares of the company outperformed the industry over the past one year. However, adverse foreign exchange rate volatility impact and mounting operating losses are headwinds.”

Several other research firms have also recently commented on HUBS. Rosenblatt Securities assumed coverage on HubSpot in a research report on Thursday, October 4th. They set a “buy” rating and a $170.00 target price for the company. Oppenheimer boosted their target price on HubSpot from $150.00 to $160.00 and gave the stock an “outperform” rating in a research report on Thursday, November 8th. Morgan Stanley boosted their target price on HubSpot from $141.00 to $146.00 and gave the stock an “equal weight” rating in a research report on Thursday, November 8th. Raymond James boosted their target price on HubSpot from $150.00 to $155.00 and gave the stock an “outperform” rating in a research report on Thursday, November 8th. Finally, Jefferies Financial Group assumed coverage on HubSpot in a research report on Tuesday, October 2nd. They set a “buy” rating and a $182.00 target price for the company. Five equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $147.13.

Shares of NYSE HUBS traded up $0.95 during mid-day trading on Thursday, hitting $139.36. The company had a trading volume of 3,267 shares, compared to its average volume of 513,700. The stock has a market cap of $4.97 billion, a PE ratio of -136.63 and a beta of 1.80. HubSpot has a 1 year low of $85.65 and a 1 year high of $162.20. The company has a debt-to-equity ratio of 1.37, a quick ratio of 3.15 and a current ratio of 3.15.

HubSpot (NYSE:HUBS) last announced its quarterly earnings results on Wednesday, November 7th. The software maker reported ($0.32) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.37). The company had revenue of $131.83 million during the quarter, compared to analysts’ expectations of $126.65 million. HubSpot had a negative net margin of 13.43% and a negative return on equity of 19.13%. HubSpot’s revenue for the quarter was up 34.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.03 earnings per share. On average, sell-side analysts predict that HubSpot will post -0.98 EPS for the current year.

In other HubSpot news, insider Hunter Madeley sold 1,000 shares of HubSpot stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $137.61, for a total transaction of $137,610.00. Following the completion of the sale, the insider now owns 36,797 shares of the company’s stock, valued at $5,063,635.17. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Brian Halligan sold 15,277 shares of HubSpot stock in a transaction dated Thursday, December 20th. The stock was sold at an average price of $123.18, for a total value of $1,881,820.86. Following the sale, the chief executive officer now directly owns 680,046 shares of the company’s stock, valued at approximately $83,768,066.28. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 68,545 shares of company stock valued at $8,654,536. Corporate insiders own 9.60% of the company’s stock.

Hedge funds have recently modified their holdings of the business. DekaBank Deutsche Girozentrale lifted its stake in shares of HubSpot by 85.6% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 835 shares of the software maker’s stock valued at $119,000 after acquiring an additional 385 shares during the last quarter. American International Group Inc. lifted its stake in shares of HubSpot by 1.8% in the 3rd quarter. American International Group Inc. now owns 24,054 shares of the software maker’s stock valued at $3,631,000 after acquiring an additional 434 shares during the last quarter. MetLife Investment Advisors LLC lifted its stake in shares of HubSpot by 4.6% in the 2nd quarter. MetLife Investment Advisors LLC now owns 16,478 shares of the software maker’s stock valued at $2,066,000 after acquiring an additional 719 shares during the last quarter. Raymond James & Associates lifted its stake in shares of HubSpot by 4.0% in the 2nd quarter. Raymond James & Associates now owns 20,444 shares of the software maker’s stock valued at $2,564,000 after acquiring an additional 782 shares during the last quarter. Finally, Paloma Partners Management Co lifted its stake in shares of HubSpot by 36.9% in the 3rd quarter. Paloma Partners Management Co now owns 3,009 shares of the software maker’s stock valued at $454,000 after acquiring an additional 811 shares during the last quarter. 93.62% of the stock is owned by hedge funds and other institutional investors.

About HubSpot

HubSpot, Inc provides a cloud-based marketing and sales software platform for businesses in the Americas, Europe, and the Asia Pacific. Its software platform includes integrated applications, such as social media, search engine optimization, blogging, Website content management, marketing automation, email, sales productivity, CRM, analytics, and reporting.

Featured Story: Diversification For Individual Investors

Get a free copy of the Zacks research report on HubSpot (HUBS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HubSpot (NYSE:HUBS)

Receive News & Ratings for HubSpot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HubSpot and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Oppenheimer Lowers Regal Beloit  to Market Perform
Oppenheimer Lowers Regal Beloit to Market Perform
Ranger Energy Services  Stock Rating Upgraded by Zacks Investment Research
Ranger Energy Services Stock Rating Upgraded by Zacks Investment Research
HubSpot  Lowered to Hold at Zacks Investment Research
HubSpot Lowered to Hold at Zacks Investment Research
Maxim Integrated Products  Lifted to “Hold” at Zacks Investment Research
Maxim Integrated Products Lifted to “Hold” at Zacks Investment Research
Arista Networks Inc  Given Consensus Rating of “Buy” by Analysts
Arista Networks Inc Given Consensus Rating of “Buy” by Analysts
Brokerages Set Regeneron Pharmaceuticals Inc  Target Price at $394.19
Brokerages Set Regeneron Pharmaceuticals Inc Target Price at $394.19


Leave a Reply

© 2006-2019 Ticker Report